PROGRAM AGENDA
*Panels are in development and speakers are subject to change.
Registration + Networking Breakfast
7:00 – 8:00 a.m.
Registration and breakfast
​
Welcome Remarks
8:00 – 8:15 a.m.
Welcome and Overview of Eyecelerator @ AAO 2024​
​
-
Stephen D. McLeod, MD, CEO, American Academy of Ophthalmology
-
Allen C. Ho, MD, Retina Program Director
-
Gil Kliman, MD, Program Director
S1: Strategic Sight: Financial and Commercial Update
8:15 – 8:45 a.m.
An overview of financial and commercial aspects of ophthalmic innovation: are these good times or bad times?
​
​Panel:
-
Sergio Rossi, Managing Director and Partner, Boston Consulting Group
-
Kristen Harmon Ingenito, CEO, Market Scope
-
Andrew Gitkin, Senior Managing Director, Healthcare Investment Banking, Leerink Partners LLC
-
Jeffry Weinhuff, Managing Partner, Visionary Ventures
​
S2: Lessons Learned: Impact of Practice Dynamics on Innovative Therapies
8:45 – 9:30 a.m.
A candid discussion of successes and failures of innovation integration into clinical practice.
​
Introduction: Gil Kliman, MD
​
Keynote: Barriers to Adoption of Technology in the Retina Space
Reginald Sanders, MD
​
Moderator: Reginald Sanders, MD
Panel:
-
David Eichenbaum, MD, Retina Vitreous Associates of Florida
-
J. Michael Jumper, MD, West Coast Retina
-
Cathleen M. McCabe, MD, Chief Medical Officer, Eye Health America
-
Erin Powers, Vice President, US Sales & Marketing for Surgical Vision, Johnson & Johnson
-
Lejla Vajzovic, MD, Associate Professor of Ophthalmology, Duke University
-
Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas
Networking Break
9:30 – 10:00 a.m.
Networking Break
S3: Fueling Progress: The Power of Innovation and Perseverance
10:00 – 11:00 a.m.
True innovation is often a long journey, requiring persistence and dedication. How do you maintain focus and drive toward achieving your ultimate vision?
​
Moderators:
-
Robert L. Avery, MD and Allen C. Ho, MD
-
Fireside chat with Leonard S. Schleifer, MD, PhD and George D. Yancopoulos, MD, PhD
Presentation of the Eyecelerator Innovation Award presented to Dr. Schleifer and Dr. Yancopoulos.
​
​Panel:
-
Pravin Dugel, MD, Executive Chair, President, and CEO, Ocular Therapeutix, Inc.
-
Cedric Francois, MD, PhD, Co-Founder and CEO, Apellis Pharmaceuticals
-
David Guyer, MD, CEO, EyeBio
-
Leonard S. Schleifer, MD, President and CEO, Regeneron
-
Dan Schwartz, MD, Director, Retina Division, SF VA Medical Center
-
George D. Yancopoulos, MD, PhD, President and Chief Scientific Officer, Regeneron
​
S4: Unexpected Bottlenecks in Glaucoma Innovation
11:00 – 11:45 a.m.
Many factors can slow or block innovation. FDA, reimbursement, and practice dynamics all can impede advancement to the marketplace. Patent wars are beginning to stifle innovation as companies are spending more money on legal fees than R&D. Is incremental innovation becoming more of the norm due to increasing barriers to disruptive innovation?
​
Moderators: Nathan M. Radcliffe, MD and Oluwatosin U. Smith, MD
Panel:
-
Reay H. Brown, MD, Chief Medical Officer, Sight Sciences
-
Gus DeMoraes, MD, PhD, MPH, Chief Medical Officer, ORA
-
Kate Hunt, Chief Commercial Officer Nova Eye Medical
-
Rajesh Rajpal, MD, Chief Medical Officer, Vision, Johnson & Johnson
-
Ramin Valian, AbbVie, VP, Eyecare & Global Pipeline & Commercialization Strategy
​
The Winning Pitch Challenge
11:45 a.m. – 12:30 p.m.
The Shark Tank-style competition features pitches from three early-stage ophthalmology innovators, with judges and the audience deciding who will take home cash prizes worth $45,000.
​
Moderators: Vance Thompson, MD, and John Berdahl, MD​
​​Judges: ​
-
Anne Fung, MD
-
Adrienne Graves, PhD
-
Robert Warner
​​
Networking Lunch
12:30 – 1:15 p.m.
Enjoy a bite to eat with your colleagues.
Presenting Company Showcases
1:15 – 3:00 p.m.
Thirty-nine companies present innovative new treatments, products, and services. Three breakout rooms will operate simultaneously for each segment. Links for showcase schedules will be posted shortly:
​
Anterior Segment - Room E353c
Glaucoma & Digital - Room E451b
Retina - Room E450a
Networking Break
3:00 – 3:30 p.m.
Networking Break
​
S5: Navigating the Regulatory Pathways for Anterior Segment Innovations: Insights from FDA and Industry Leaders
3:30 – 4:15 p.m.
This panel will discuss the intricacies of the regulatory process with a focus on accelerated approvals, strategies for securing approvals, and the development of new endpoints, including surrogate endpoints, and functional vision assessments.
​
Moderators: Zaina Al-Mohtaseb, MD, and Arsham Sheybani, MD
Panel:
​​
-
Jeannette Bankes, SVP, Group President, Global Franchises Surgical & Vision Care, Alcon
-
William Boyd, MD, Deputy Division Director, Division of Ophthalmology, FDA
-
Malvina Eydelman, MD, Director of The Office Of Ophthalmic, Anesthesia, Respiratory, ENT And Dental Devices, FDA
-
Cherie Fathy, MD, Medical Officer, FDA
-
Keeley Puls-Boever, Executive Director, True North
Closing Bell and People's Choice Awards
4:15 – 4:30 p.m.
The program committee wraps the day with the People's Choice recognition of best presenting company by segment.
​
-
Zaina Al-Mohtaseb, MD, Program Co-Chair
-
Robert L. Avery, MD, Program Co-Chair
-
Allen C. Ho, MD, Retina Program Director
-
Gil Kliman, MD, Program Director
-
Arsham Sheybani, MD, Program Co-Chair
Reception
4:30 – 5:15 p.m.
Enjoy refreshments and connect!
​